Glucocorticoids are the most effective treatment for asthma and other inflammatory diseases of the airways. New evidence now suggests that bronchoconstriction following experimental antigen challenge of asthmatic subjects is influenced by endogenous glucocorticoids (EG), and that antigen challenge induces an increase in circulating levels of EG. Exciting preliminary results indicate that the response of human airway epithelial cells to glucocorticoids is regulated by (11beta-HSD), a glucocorticoid-degrading enzyme which is highly expressed in airway epithelial cells. Studies described in Aim 1 of this proposal are designed to elucidate the mechanism of the increase of EG in allergic subjects following inhaled antigen challenge. Plasma cortisol, cortisone and corticotropin levels will be assayed and the influence of EG on the pulmonary early and late phase reactions will be explored. Whether bronchospasm causes the rise of EG after antigen challenge will be determined pharmacologically with drugs that modify bronchospasm (methacholine and salmeterol). Studies with metyrapone will assess the role of de novo synthesis of cortisol in the adrenal gland. Studies in Aim 2 are designed to establish the importance of 11beta-HSD in regulating the inflammatory response to intranasal antigen challenge using carbenoxolone, a potent 11beta-HSD inhibitor. In these studies we will monitor 11beta- HSD expression and function using RT-PCR and a highly sensitive and selective GC-MS assay for endogenous glucocorticoids in the airways. Studies in Aim 3 will test the hypothesis that 11beta- HSD reduces the access of cortisol to glucocorticoid receptors in airway epithelial cells. These studies will utilize epithelial cells that express 11beta-HSD and those that do not, and compare the ability of an 11beta-HSD inhibitor to potentiate the inhibitory effects of cortisol on the secretion of GM-CSF, RANTES and eotaxin. Mechanistic studies in this aim will utilize 11beta-HSD-transfected cells to establish specificity of observed effects. Studies of the influence of cortisol and 11beta-HSD on chemokine mRNA stability are planned. Since in vivo studies indicate that airway challenge increases EG, studies in Aim 4 will search for airway-derived factors that induce cortisol secretion from cultured human adrenal cells. Studies to confirm and elucidate the mechanism of exciting preliminary results showing that RANTES induces high levels of cortisol release are planned. There is clearly a dynamic interrelationship between airway inflammation and EG. An improved understanding of this relationship is likely to lead to new opportunities to exploit this system for therapeutic benefit.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI044885-03
Application #
6374083
Study Section
Special Emphasis Panel (ZRG1-RAP (01))
Program Officer
Adams, Ken
Project Start
1999-04-01
Project End
2004-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
3
Fiscal Year
2001
Total Cost
$388,478
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Mahdavinia, Mahboobeh; Hsu, Joy; Norton, James E et al. (2015) Association of common filaggrin null mutations with atopy but not chronic rhinosinusitis. Ann Allergy Asthma Immunol 114:420-421
Heller, N M; Matsukura, S; Georas, S N et al. (2004) Assessment of signal transducer and activator of transcription 6 as a target of glucocorticoid action in human airway epithelial cells. Clin Exp Allergy 34:1690-700
Sha, Quan; Truong-Tran, Ai Q; Plitt, James R et al. (2004) Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 31:358-64
Matsukura, Satoshi; Kokubu, Fumio; Kuga, Hideki et al. (2003) Differential regulation of eotaxin expression by IFN-gamma in airway epithelial cells. J Allergy Clin Immunol 111:1337-44
Schroeder, J T; Schleimer, R P; Lichtenstein, L M et al. (2001) Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy 31:1369-77
Liu, M C; Proud, D; Lichtenstein, L M et al. (2001) Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol 108:29-38
Hubbard, W C; Liu, M C; Bickel, C et al. (2001) Measurement of low picomolar levels of triamcinolone acetonide in human bronchoalveolar lavage fluid by gas chromatography-electron-capture negative-ion mass spectrometry. Anal Biochem 290:18-25
Matsukura, S; Stellato, C; Georas, S N et al. (2001) Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol 24:755-61
Shahabuddin, S; Ponath, P; Schleimer, R P (2000) Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines. J Immunol 164:3847-54
Stellato, C; Matsukura, S; Fal, A et al. (1999) Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol 163:5624-32

Showing the most recent 10 out of 12 publications